Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8836
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSabah-Ozcan, S.-
dc.contributor.authorBaser, A.-
dc.contributor.authorÖlçücü, Taha-
dc.contributor.authorBarış, İkbal Cansu-
dc.contributor.authorElmas, Levent-
dc.contributor.authorTuncay, Levent-
dc.contributor.authorEskicorapci, S.-
dc.date.accessioned2019-08-16T12:56:56Z-
dc.date.available2019-08-16T12:56:56Z-
dc.date.issued2017-
dc.identifier.issn1078-1439-
dc.identifier.urihttps://hdl.handle.net/11499/8836-
dc.identifier.urihttps://doi.org/10.1016/j.urolonc.2017.07.029-
dc.description.abstractPurpose Toll-like receptors (TLRs) have an important role in the activation of both innate and adaptive immunity in response to pathogens and endogenous danger signals from damaged or dying cells. The aim of this study was to determine the relationship between urothelial carcinoma (UC) and TLR expression. Basic procedures Real-time polymerase chain reaction evaluation was made of the messenger RNA expression of TLRs 1–10 in 24 UC samples and 46 nontumoral bladder tissue samples. The levels of proinflammatory cytokines (IL-1ß IL-6, and IL-8) in the urine samples were also determined with enzyme-linked immunosorbent assay. Main findings TLR2–7 and TLR10 expressions were significantly higher in UC than in the control group (P<0.05 for all comparisons). No concordance was found between matched tumor tissue and urine samples in terms of TLR expression. IL-1ß IL-6, and IL-8 levels were significantly higher in urine specimens of patients with UC (P = 0.033, P = 0.001, and P = 0.008, respectively). Principal conclusions The results of this study demonstrated that the TLR gene expression profiles reflect the heterogeneity within UC. These results might also prompt further investigation to better understand the role of the TLR gene family expression in the tumor progression of UC. © 2017 Elsevier Inc.en_US
dc.language.isoenen_US
dc.publisherElsevier Inc.en_US
dc.relation.ispartofUrologic Oncology: Seminars and Original Investigationsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectProinflammatory cytokinesen_US
dc.subjectTLR expressionen_US
dc.subjectUrineen_US
dc.subjectUrothelial carcinomaen_US
dc.subjectinterleukin 1betaen_US
dc.subjectinterleukin 6en_US
dc.subjectinterleukin 8en_US
dc.subjectmessenger RNAen_US
dc.subjecttoll like receptoren_US
dc.subjecttoll like receptor 10en_US
dc.subjecttoll like receptor 2en_US
dc.subjecttoll like receptor 3en_US
dc.subjecttoll like receptor 4en_US
dc.subjecttoll like receptor 5en_US
dc.subjecttoll like receptor 6en_US
dc.subjecttoll like receptor 7en_US
dc.subjectautacoiden_US
dc.subjectcytokineen_US
dc.subjectisoproteinen_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectArticleen_US
dc.subjectbladder carcinomaen_US
dc.subjectbladder injuryen_US
dc.subjectcancer stagingen_US
dc.subjectclinical articleen_US
dc.subjectenzyme linked immunosorbent assayen_US
dc.subjectfemaleen_US
dc.subjectgene expressionen_US
dc.subjecthumanen_US
dc.subjectmaleen_US
dc.subjectneoplasmen_US
dc.subjectpriority journalen_US
dc.subjectreal time polymerase chain reactionen_US
dc.subjectRNA isolationen_US
dc.subjecttransitional cell carcinomaen_US
dc.subjecttumor volumeen_US
dc.subjectvery elderlyen_US
dc.subjectbladder tumoren_US
dc.subjectgene expression profilingen_US
dc.subjectgene expression regulationen_US
dc.subjectgeneticsen_US
dc.subjectmiddle ageden_US
dc.subjectmultigene familyen_US
dc.subjecturineen_US
dc.subjectAgeden_US
dc.subjectAged, 80 and overen_US
dc.subjectCarcinoma, Transitional Cellen_US
dc.subjectCytokinesen_US
dc.subjectFemaleen_US
dc.subjectGene Expression Profilingen_US
dc.subjectGene Expression Regulation, Neoplasticen_US
dc.subjectHumansen_US
dc.subjectInflammation Mediatorsen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectMultigene Familyen_US
dc.subjectProtein Isoformsen_US
dc.subjectToll-Like Receptorsen_US
dc.subjectUrinary Bladder Neoplasmsen_US
dc.titleHuman TLR gene family members are differentially expressed in patients with urothelial carcinoma of the bladderen_US
dc.typeArticleen_US
dc.identifier.volume35en_US
dc.identifier.issue12en_US
dc.identifier.startpage674.e11-
dc.identifier.startpage674.e11en_US
dc.identifier.endpage674.e17en_US
dc.authorid0000-0002-4721-2807-
dc.authorid0000-0002-8802-3471-
dc.authorid0000-0002-6865-6466-
dc.authorid0000-0003-4631-6337-
dc.authorid0000-0002-8294-558X-
dc.authorid0000-0003-0980-9335-
dc.identifier.doi10.1016/j.urolonc.2017.07.029-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid28843340en_US
dc.identifier.scopus2-s2.0-85028344595en_US
dc.identifier.wosWOS:000415298200016en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.dept14.03. Basic Medical Sciences-
crisitem.author.dept14.03. Basic Medical Sciences-
crisitem.author.dept14.01. Surgical Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

5
checked on Oct 13, 2024

WEB OF SCIENCETM
Citations

4
checked on Dec 18, 2024

Page view(s)

50
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.